ranolazine has been researched along with Neuralgia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SR; Diamond, I; Gould, HJ; Hernandez, C; Paul, D; Soignier, RD; Taylor, BK | 1 |
| Diamond, I; Gould, HJ | 1 |
| Diamond, I; Donahue, RR; Garrett, C; Gould, HJ; Paul, D; Taylor, BK | 1 |
| Nodera, H; Rutkove, SB | 1 |
4 other study(ies) available for ranolazine and Neuralgia
| Article | Year |
|---|---|
Ranolazine attenuates mechanical allodynia associated with demyelination injury.
Topics: Acetanilides; Animals; Demyelinating Diseases; Disease Models, Animal; Enzyme Inhibitors; Hyperalgesia; Male; Neuralgia; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2014 |
Ranolazine: A potential treatment for refractory neuropathic pain.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Ranolazine; Sodium Channel Blockers; Young Adult | 2016 |
Ranolazine attenuates behavioral signs of neuropathic pain.
Topics: Acetanilides; Animals; Ataxia; Behavior, Animal; Cold Temperature; Drug Evaluation, Preclinical; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Nervous System Diseases; Neuralgia; Pain Measurement; Pain Threshold; Physical Stimulation; Piperazines; Random Allocation; Ranolazine; Rats; Rats, Sprague-Dawley; Reaction Time; Sodium Channel Blockers | 2009 |
Changes of the peripheral nerve excitability in vivo induced by the persistent Na+ current blocker ranolazine.
Topics: Acetanilides; Action Potentials; Animals; Axons; Electric Stimulation; Male; Mice; Neuralgia; Peripheral Nerves; Piperazines; Ranolazine; Sensory Thresholds; Sodium Channel Blockers; Sodium Channels | 2012 |